Northwind Pharmaceuticals LLC FDA Record
- Latest inspection VAI · Sep 26, 2025
- No warning letters matched by name
Northwind Pharmaceuticals LLC has 13 FDA recalls, 6 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Northwind Pharmaceuticals LLC" is on file.
- Latest recall
- D-0654-2025 · Class II · Aug 20, 2025
- Latest inspection
- Sep 26, 2025 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 13 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 6 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Northwind Pharmaceuticals LLC: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 1 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 7 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 4 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Northwind Pharmaceuticals LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Northwind Pharmaceuticals LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0654-2025 | Class II | Sulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength packaged in a) 6-count… | Aug 20, 2025 |
| D-0548-2023 | Class II | Atorvastatin Calcium Tablets, USP, 10 mg, 30-count bottles, Rx Only, Repackaged By: Northwind… | Mar 16, 2023 |
| D-0550-2023 | Class II | Doxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals… | Mar 16, 2023 |
| D-0553-2023 | Class II | Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count… | Mar 16, 2023 |
| D-0551-2023 | Class II | Glimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and b)90-count… | Mar 16, 2023 |
| D-0549-2023 | Class II | BusPIRone Hydrochloride Tablets USP, 7.5 mg, 30-count bottles, Rx Only, Repackaged By: NOrthwind… | Mar 16, 2023 |
| D-0552-2023 | Class II | Glimepiride Tablets, USP 4mg, packaged in a) 30-count bottles (NDC 51655-120-52), and b) 90-count… | Mar 16, 2023 |
| D-0554-2023 | Class II | Tadalafil Tablets, USP 5 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals… | Mar 16, 2023 |
| D-1097-2018 | Class II | Valsartan, 80mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals… | Jul 18, 2018 |
| D-1098-2018 | Class II | Valsartan, 320mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals… | Jul 18, 2018 |
| D-1096-2018 | Class II | Valsartan HCTZ, 160/12.5mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind… | Jul 18, 2018 |
| D-1095-2018 | Class II | Valsartan, 160 mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals… | Jul 18, 2018 |
| D-0485-2016 | Class III | Prednisone 20 mg, Tablet, 10-count bottle, Rx only, Mfg by: HIKMA Pharmaceuticals PO BOX 182400… | Nov 10, 2015 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Sep 26, 2025 | Indianapolis, IN | Drugs | Voluntary Action Indicated (VAI) | 1831143 |
| Nov 16, 2018 | Indianapolis, IN | Drugs | Voluntary Action Indicated (VAI) | 1831143 |
| Mar 13, 2017 | Indianapolis, IN | Drugs | No Action Indicated (NAI) | 1831143 |
| Dec 9, 2015 | Indianapolis, IN | Drugs | Official Action Indicated (OAI) | 1831143 |
| Sep 14, 2015 | Indianapolis, IN | Drugs | Voluntary Action Indicated (VAI) | 1831143 |
| Oct 14, 2014 | Indianapolis, IN | Drugs | No Action Indicated (NAI) | 1831143 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 1831143 | Indianapolis, IN | 6 | Sep 26, 2025 |
Northwind Pharmaceuticals LLC and the FDA: common questions
Has Northwind Pharmaceuticals LLC received an FDA warning letter?
No FDA warning letter addressed to the name "Northwind Pharmaceuticals LLC" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Northwind Pharmaceuticals LLC received an FDA Form 483?
FDA has not published a Form 483 for "Northwind Pharmaceuticals LLC" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Northwind Pharmaceuticals LLC?
The most recent FDA inspection on file ended Sep 26, 2025 at Indianapolis, IN and was classified VAI. FDA has 6 inspections of Northwind Pharmaceuticals LLC on file, 1 of them classified OAI (official action indicated).
Has Northwind Pharmaceuticals LLC had an FDA recall?
Yes. Northwind Pharmaceuticals LLC has 13 FDA recalls on record. The most recent started Aug 20, 2025.
Need more than this page shows? Ask about Northwind Pharmaceuticals LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.